Review: taking Naproxen sodium and Mucinex d together


Summary

Drug interactions are reported among people who take Naproxen sodium and Mucinex d together. This review analyzes the effectiveness and drug interactions between Naproxen sodium and Mucinex d. It is created by eHealthMe based on reports of 33 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Naproxen Sodium

Naproxen sodium has active ingredients of naproxen sodium. It is often used in pain. (latest outcomes from Naproxen sodium 5,254 users)

Mucinex D

Mucinex d has active ingredients of guaifenesin; pseudoephedrine hydrochloride. It is often used in sinus congestion. (latest outcomes from Mucinex d 768 users)

On Sep, 17, 2016

33 people who take Naproxen Sodium, Mucinex D are studied.


Number of reports submitted per year:

Naproxen sodium and Mucinex d drug interactions.

Drug effectiveness over time:

Naproxen Sodium:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Mucinex D:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Naproxen Sodium:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)
Mucinex D:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Naproxen Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Mucinex D:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • vasculitis
  • atrial fibrillation
  • chest pain
  • diabetes mellitus
  • renal failure acute
6 - 12 months:
  • atrial fibrillation
  • diabetes mellitus
  • renal failure acute
  • vasculitis
  • inflammation localised
1 - 2 years:
  • inflammation localised
not specified:
  • atrial fibrillation
  • diabetes mellitus
  • renal failure acute
  • vasculitis
  • nausea
  • fatigue
  • asthenia
  • headache
  • pain
  • pyrexia

Most common drug interactions by gender *:

female:
  • atrial fibrillation
  • diabetes mellitus
  • renal failure acute
  • vasculitis
  • nausea
  • fatigue
  • asthenia
  • headache
  • pain
  • pyrexia
male:
  • agitation
  • bipolar disorder
  • cholecystitis chronic
  • cholelithiasis
  • heart rate increased
  • nephrolithiasis
  • pericardial effusion
  • platelet count decreased
  • psychotic disorder
  • white blood cell count decreased

Most common drug interactions by age *:

10-19:
  • deep vein thrombosis
  • pulmonary embolism
  • heart rate increased
  • injury
  • pain
20-29:
  • abdominal pain upper
  • asthenia
  • cholecystitis
  • cholelithiasis
  • nausea
  • pancreatitis
  • pyrexia
  • vomiting
  • chest pain
  • oedema peripheral
30-39:
  • inflammation localised
  • dry mouth
  • fatigue
  • irritability
  • nausea
  • sedation
40-49:
  • abdominal distension
  • depression
  • dermatitis herpetiformis
  • fatigue
  • fluid retention
  • insomnia
  • pain in extremity
  • peripheral swelling
  • rash papular
  • rash pruritic
50-59:
  • anaemia
  • fatigue
  • headache
  • nausea
  • pyrexia
  • abdominal pain
  • alopecia
  • asocial behaviour
  • asthenia
  • back pain
60+:
  • atrial fibrillation
  • diabetes mellitus
  • renal failure acute
  • vasculitis
  • nephrolithiasis
  • agitation
  • anxiety
  • asthenia
  • bipolar disorder
  • blood pressure decreased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Naproxen sodium and Mucinex d?

You may be interested in these reviews

More reviews for: Naproxen sodium, Mucinex d

On eHealthMe, Naproxen sodium (naproxen sodium) is often used to treat pain. Mucinex d (guaifenesin; pseudoephedrine hydrochloride) is often used to treat sinus congestion. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.